Items where authors include "Eeles, R"
Up a levelArticle
Marques, P, Caimari, F, Hernández-RamÃrez, LC et al. (280 more authors) (2020) Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors. The Journal of Clinical Endocrinology & Metabolism, 105 (6). ISSN 0021-972X
Copson, ER, Maishman, TC, Tapper, WJ et al. (21 more authors) (2018) Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. The Lancet Oncology, 19 (2). pp. 169-180. ISSN 1470-2045
Litchfield, K, Levy, M, Orlando, G et al. (30 more authors) (2017) Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor. Nature Genetics, 49 (7). pp. 1133-1140. ISSN 1061-4036
Abbosh, C, Birkbak, NJ, Wilson, GA et al. (425 more authors) (2017) Phylogenetic ctDNA analysis depicts early stage lung cancer evolution. Nature, 545. pp. 446-451. ISSN 0028-0836
Mateo, J, Carreira, S, Sandhu, S et al. (48 more authors) (2015) DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. New England Journal of Medicine, 373 (18). pp. 1697-1708. ISSN 0028-4793
Litchfield, K, Holroyd, A, Lloyd, A et al. (14 more authors) (2015) Identification of four new susceptibility loci for testicular germ cell tumour. Nature Communications, 6. 8690. ISSN 2041-1723
Litchfield, K, Sultana, R, Renwick, A et al. (17 more authors) (2015) Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25. Human Molecular Genetics, 24 (4). 1169 - 1176. ISSN 0964-6906
Ruark, E, Seal, S, McDonald, H et al. (18 more authors) (2013) Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nature Genetics, 45 (6). pp. 686-689. ISSN 1061-4036
Proceedings Paper
Sandhu, S, Mateo, J, Miranda, S et al. (31 more authors) (2015) Antitumour Activity of the Poly(Adp-Ribose) Polymerase (Parp) Inhibitor Olaparib in Unselected Sporadic Castration Resistant Prostate Cancer (Crpc) in the Toparp Trial. In: Asia-Pacific Journal of Clinical Oncology. ANZUP Annual Scientific Meeting: Redefining Personalised Medicine, 12-14 Jul 2015, Sydney, Australia. Wiley , pp. 28-29.